APO Research
Talk to an analyst

APO RESEARCH · REPORT

Genetic Disorders Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Genetic Disorders Drug Industry Growth and Trends Forecast to 2032

20 December 202595 pages

Choose your research edition.

Industry ResearchGenetic Disorders Drug Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Genetic Disorders Drug Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Genetic Disorders Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genetic Disorders Drug Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Genetic Disorders Drug Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Genetic Disorders Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Genetic Disorders Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Genetic Disorders Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Genetic Disorders Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Genetic Disorders Drug include Takeda, Sanofi, Pfizer, Amgen, Vertex, Sarepta, GW Pharmaceuticals and BioMarin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Genetic Disorders Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Genetic Disorders Drug market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Genetic Disorders Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Genetic Disorders Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Genetic Disorders Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Genetic Disorders Drug Market by Company

Takeda

Sanofi

Pfizer

Amgen

Vertex

Sarepta

GW Pharmaceuticals

BioMarin

Genetic Disorders Drug Segment by Type

Duchenne Muscular Dystrophy (DMD)

Cystic Fibrosis (CF)

Lysosomal Storage Disease (LSD)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Genetic Disorders Drug Segment by Application

Clinic

Hospital

Genetic Disorders Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetic Disorders Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genetic Disorders Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetic Disorders Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Genetic Disorders Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Genetic Disorders Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Duchenne Muscular Dystrophy (DMD) Table 2. Major Company of Cystic Fibrosis (CF) Table 3. Major Company of Lysosomal Storage Disease (LSD) Table 4. Major Company of Paroxysmal Nocturnal Hemoglobinuria (PNH) Table 5. Global Genetic Disorders Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Genetic Disorders Drug Sales by Type (2021-2026) & (W Units) Table 7. Global Genetic Disorders Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global Genetic Disorders Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global Genetic Disorders Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global Genetic Disorders Drug Price by Type (2021-2026) & (US$/Unit) Table 11. Global Genetic Disorders Drug Sales by Type (2027-2032) & (W Units) Table 12. Global Genetic Disorders Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global Genetic Disorders Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global Genetic Disorders Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global Genetic Disorders Drug Price by Type (2027-2032) & (US$/Unit) Table 16. North America Genetic Disorders Drug Sales by Type (2021-2026) & (W Units) Table 17. North America Genetic Disorders Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Genetic Disorders Drug Sales by Type (2021-2026) & (W Units) Table 19. Europe Genetic Disorders Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Genetic Disorders Drug Sales by Type (2021-2026) & (W Units) Table 21. Asia-Pacific Genetic Disorders Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Genetic Disorders Drug Sales by Type (2021-2026) & (W Units) Table 23. Latin America Genetic Disorders Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Genetic Disorders Drug Sales by Type (2021-2026) & (W Units) Table 25. Middle East and Africa Genetic Disorders Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Genetic Disorders Drug Industry Trends Table 27. Genetic Disorders Drug Industry Drivers Table 28. Genetic Disorders Drug Industry Opportunities and Challenges Table 29. Genetic Disorders Drug Industry Restraints Table 30. Global Genetic Disorders Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Genetic Disorders Drug Revenue Market Share by Company (2021-2026) Table 32. Global Genetic Disorders Drug Sales by Company (2021-2026) & (W Units) Table 33. Global Genetic Disorders Drug Sales Share by Company (2021-2026) Table 34. Global Genetic Disorders Drug Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Genetic Disorders Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Genetic Disorders Drug Major Company Production Sites and Headquarters Table 37. Global Genetic Disorders Drug Company, Product Type & Application Table 38. Global Genetic Disorders Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Genetic Disorders Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Genetic Disorders Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Genetic Disorders Drug Sales by Region (2021-2026) & (W Units) Table 43. Global Genetic Disorders Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global Genetic Disorders Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global Genetic Disorders Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global Genetic Disorders Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Genetic Disorders Drug Sales by Region (2027-2032) & (W Units) Table 48. Global Genetic Disorders Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global Genetic Disorders Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global Genetic Disorders Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global Genetic Disorders Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Genetic Disorders Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Genetic Disorders Drug Sales by Application (2021-2026) & (W Units) Table 54. Global Genetic Disorders Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global Genetic Disorders Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global Genetic Disorders Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global Genetic Disorders Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global Genetic Disorders Drug Sales by Application (2027-2032) & (W Units) Table 59. Global Genetic Disorders Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global Genetic Disorders Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global Genetic Disorders Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global Genetic Disorders Drug Price by Application (2027-2032) & (US$/Unit) Table 63. North America Genetic Disorders Drug Sales by Application (2021-2026) & (W Units) Table 64. North America Genetic Disorders Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Genetic Disorders Drug Sales by Application (2021-2026) & (W Units) Table 66. Europe Genetic Disorders Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Genetic Disorders Drug Sales by Application (2021-2026) & (W Units) Table 68. Asia-Pacific Genetic Disorders Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Genetic Disorders Drug Sales by Application (2021-2026) & (W Units) Table 70. Latin America Genetic Disorders Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Genetic Disorders Drug Sales by Application (2021-2026) & (W Units) Table 72. Middle East and Africa Genetic Disorders Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Takeda Company Information Table 74. Takeda Business Overview Table 75. Takeda Genetic Disorders Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Takeda Genetic Disorders Drug Product Portfolio Table 77. Takeda Recent Development Table 78. Sanofi Company Information Table 79. Sanofi Business Overview Table 80. Sanofi Genetic Disorders Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Sanofi Genetic Disorders Drug Product Portfolio Table 82. Sanofi Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Genetic Disorders Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Pfizer Genetic Disorders Drug Product Portfolio Table 87. Pfizer Recent Development Table 88. Amgen Company Information Table 89. Amgen Business Overview Table 90. Amgen Genetic Disorders Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Amgen Genetic Disorders Drug Product Portfolio Table 92. Amgen Recent Development Table 93. Vertex Company Information Table 94. Vertex Business Overview Table 95. Vertex Genetic Disorders Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Vertex Genetic Disorders Drug Product Portfolio Table 97. Vertex Recent Development Table 98. Sarepta Company Information Table 99. Sarepta Business Overview Table 100. Sarepta Genetic Disorders Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Sarepta Genetic Disorders Drug Product Portfolio Table 102. Sarepta Recent Development Table 103. GW Pharmaceuticals Company Information Table 104. GW Pharmaceuticals Business Overview Table 105. GW Pharmaceuticals Genetic Disorders Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. GW Pharmaceuticals Genetic Disorders Drug Product Portfolio Table 107. GW Pharmaceuticals Recent Development Table 108. BioMarin Company Information Table 109. BioMarin Business Overview Table 110. BioMarin Genetic Disorders Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. BioMarin Genetic Disorders Drug Product Portfolio Table 112. BioMarin Recent Development Table 113. North America Genetic Disorders Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 114. North America Genetic Disorders Drug Sales by Country (2021-2026) & (W Units) Table 115. North America Genetic Disorders Drug Sales Market Share by Country (2021-2026) Table 116. North America Genetic Disorders Drug Sales Forecast by Country (2027-2032) & (W Units) Table 117. North America Genetic Disorders Drug Sales Market Share Forecast by Country (2027-2032) Table 118. North America Genetic Disorders Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Genetic Disorders Drug Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Genetic Disorders Drug Market Share by Country (2021-2026) Table 121. North America Genetic Disorders Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Genetic Disorders Drug Market Share Forecast by Country (2027-2032) Table 123. Europe Genetic Disorders Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 124. Europe Genetic Disorders Drug Sales by Country (2021-2026) & (W Units) Table 125. Europe Genetic Disorders Drug Sales Market Share by Country (2021-2026) Table 126. Europe Genetic Disorders Drug Sales Forecast by Country (2027-2032) & (W Units) Table 127. Europe Genetic Disorders Drug Sales Market Share Forecast by Country (2027-2032) Table 128. Europe Genetic Disorders Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Genetic Disorders Drug Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Genetic Disorders Drug Market Share by Country (2021-2026) Table 131. Europe Genetic Disorders Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Genetic Disorders Drug Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Genetic Disorders Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Genetic Disorders Drug Sales by Country (2021-2026) & (W Units) Table 135. Asia-Pacific Genetic Disorders Drug Sales Market Share by Country (2021-2026) Table 136. Asia-Pacific Genetic Disorders Drug Sales Forecast by Country (2027-2032) & (W Units) Table 137. Asia-Pacific Genetic Disorders Drug Sales Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Genetic Disorders Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Genetic Disorders Drug Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Genetic Disorders Drug Market Share by Country (2021-2026) Table 141. Asia-Pacific Genetic Disorders Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Genetic Disorders Drug Market Share Forecast by Country (2027-2032) Table 143. Latin America Genetic Disorders Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 144. Latin America Genetic Disorders Drug Sales by Country (2021-2026) & (W Units) Table 145. Latin America Genetic Disorders Drug Sales Market Share by Country (2021-2026) Table 146. Latin America Genetic Disorders Drug Sales Forecast by Country (2027-2032) & (W Units) Table 147. Latin America Genetic Disorders Drug Sales Market Share Forecast by Country (2027-2032) Table 148. Latin America Genetic Disorders Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Genetic Disorders Drug Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Genetic Disorders Drug Market Share by Country (2021-2026) Table 151. Latin America Genetic Disorders Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Genetic Disorders Drug Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Genetic Disorders Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Genetic Disorders Drug Sales by Country (2021-2026) & (W Units) Table 155. Middle East and Africa Genetic Disorders Drug Sales Market Share by Country (2021-2026) Table 156. Middle East and Africa Genetic Disorders Drug Sales Forecast by Country (2027-2032) & (W Units) Table 157. Middle East and Africa Genetic Disorders Drug Sales Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Genetic Disorders Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Genetic Disorders Drug Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East and Africa Genetic Disorders Drug Market Share by Country (2021-2026) Table 161. Middle East and Africa Genetic Disorders Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Genetic Disorders Drug Market Share Forecast by Country (2027-2032) Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Genetic Disorders Drug Distributors List Table 166. Genetic Disorders Drug Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Genetic Disorders Drug Image Figure 2. Global Genetic Disorders Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genetic Disorders Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Genetic Disorders Drug Sales (2021-2032) & (W Units) Figure 5. Duchenne Muscular Dystrophy (DMD) Image Figure 6. Global Duchenne Muscular Dystrophy (DMD) Sales YoY Growth (2021-2032) & (W Units) Figure 7. Cystic Fibrosis (CF) Image Figure 8. Global Cystic Fibrosis (CF) Sales YoY Growth (2021-2032) & (W Units) Figure 9. Lysosomal Storage Disease (LSD) Image Figure 10. Global Lysosomal Storage Disease (LSD) Sales YoY Growth (2021-2032) & (W Units) Figure 11. Paroxysmal Nocturnal Hemoglobinuria (PNH) Image Figure 12. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Sales YoY Growth (2021-2032) & (W Units) Figure 13. Global Genetic Disorders Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Genetic Disorders Drug Market Share by Type 2025 VS 2032 Figure 15. North America Genetic Disorders Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America Genetic Disorders Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe Genetic Disorders Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe Genetic Disorders Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Genetic Disorders Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Genetic Disorders Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America Genetic Disorders Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Genetic Disorders Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Genetic Disorders Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Genetic Disorders Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Genetic Disorders Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (W Units) Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 31. Global Genetic Disorders Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Genetic Disorders Drug Market Share by Application 2025 VS 2032 Figure 33. North America Genetic Disorders Drug Sales Market Share in Volume by Application in 2025 Figure 34. North America Genetic Disorders Drug Sales Market Share in Value by Application in 2025 Figure 35. Europe Genetic Disorders Drug Sales Market Share in Volume by Application in 2025 Figure 36. Europe Genetic Disorders Drug Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Genetic Disorders Drug Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Genetic Disorders Drug Sales Market Share in Value by Application in 2025 Figure 39. Latin America Genetic Disorders Drug Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Genetic Disorders Drug Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Genetic Disorders Drug Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Genetic Disorders Drug Sales Market Share in Value by Application in 2025 Figure 43. North America Genetic Disorders Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. North America Genetic Disorders Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Genetic Disorders Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Genetic Disorders Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Genetic Disorders Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Europe Genetic Disorders Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Genetic Disorders Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Genetic Disorders Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Genetic Disorders Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Asia-Pacific Genetic Disorders Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Genetic Disorders Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Genetic Disorders Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Genetic Disorders Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Latin America Genetic Disorders Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Genetic Disorders Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Genetic Disorders Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Genetic Disorders Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Middle East and Africa Genetic Disorders Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Genetic Disorders Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Genetic Disorders Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Genetic Disorders Drug Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Genetic Disorders Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Duchenne Muscular Dystrophy (DMD)
  • Cystic Fibrosis (CF)
  • Lysosomal Storage Disease (LSD)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Applications
  • Clinic
  • Hospital
Companies covered
  • Takeda
  • Sanofi
  • Pfizer
  • Amgen
  • Vertex
  • Sarepta
  • GW Pharmaceuticals
  • BioMarin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Genetic Disorders Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Genetic Disorders Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Genetic Disorders Drug Market by Type
  6. 1.3.1 Duchenne Muscular Dystrophy (DMD)
  7. 1.3.2 Cystic Fibrosis (CF)
  8. 1.3.3 Lysosomal Storage Disease (LSD)
  9. 1.3.4 Paroxysmal Nocturnal Hemoglobinuria (PNH)
  10. 1.4 Global Genetic Disorders Drug Market Size by Type
  11. 1.4.1 Global Genetic Disorders Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Genetic Disorders Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Genetic Disorders Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Genetic Disorders Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Genetic Disorders Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Genetic Disorders Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Genetic Disorders Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Genetic Disorders Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Genetic Disorders Drug Industry Trends
  2. 2.2 Genetic Disorders Drug Industry Drivers
  3. 2.3 Genetic Disorders Drug Industry Opportunities and Challenges
  4. 2.4 Genetic Disorders Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Genetic Disorders Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Genetic Disorders Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Genetic Disorders Drug Price (2021-2026)
  4. 3.4 Global Genetic Disorders Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Genetic Disorders Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Genetic Disorders Drug Company, Product Type & Application
  7. 3.7 Global Genetic Disorders Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Genetic Disorders Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Genetic Disorders Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Genetic Disorders Drug Tier 1, Tier 2, and Tier 3
4 Genetic Disorders Drug Regional Status and Outlook
  1. 4.1 Global Genetic Disorders Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Genetic Disorders Drug Historic Market Size by Region
  3. 4.2.1 Global Genetic Disorders Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Genetic Disorders Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Genetic Disorders Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Genetic Disorders Drug Forecasted Market Size by Region
  7. 4.3.1 Global Genetic Disorders Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Genetic Disorders Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Genetic Disorders Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Genetic Disorders Drug by Application
  1. 5.1 Genetic Disorders Drug Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.2 Global Genetic Disorders Drug Market Size by Application
  5. 5.2.1 Global Genetic Disorders Drug Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Genetic Disorders Drug Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Genetic Disorders Drug Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Genetic Disorders Drug Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Genetic Disorders Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Genetic Disorders Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Genetic Disorders Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Genetic Disorders Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Genetic Disorders Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Genetic Disorders Drug Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Genetic Disorders Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Genetic Disorders Drug Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Genetic Disorders Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Genetic Disorders Drug Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Amgen
  20. 6.4.1 Amgen Company Information
  21. 6.4.2 Amgen Business Overview
  22. 6.4.3 Amgen Genetic Disorders Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Amgen Genetic Disorders Drug Product Portfolio
  24. 6.4.5 Amgen Recent Developments
  25. 6.5 Vertex
  26. 6.5.1 Vertex Company Information
  27. 6.5.2 Vertex Business Overview
  28. 6.5.3 Vertex Genetic Disorders Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Vertex Genetic Disorders Drug Product Portfolio
  30. 6.5.5 Vertex Recent Developments
  31. 6.6 Sarepta
  32. 6.6.1 Sarepta Company Information
  33. 6.6.2 Sarepta Business Overview
  34. 6.6.3 Sarepta Genetic Disorders Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sarepta Genetic Disorders Drug Product Portfolio
  36. 6.6.5 Sarepta Recent Developments
  37. 6.7 GW Pharmaceuticals
  38. 6.7.1 GW Pharmaceuticals Company Information
  39. 6.7.2 GW Pharmaceuticals Business Overview
  40. 6.7.3 GW Pharmaceuticals Genetic Disorders Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GW Pharmaceuticals Genetic Disorders Drug Product Portfolio
  42. 6.7.5 GW Pharmaceuticals Recent Developments
  43. 6.8 BioMarin
  44. 6.8.1 BioMarin Company Information
  45. 6.8.2 BioMarin Business Overview
  46. 6.8.3 BioMarin Genetic Disorders Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 BioMarin Genetic Disorders Drug Product Portfolio
  48. 6.8.5 BioMarin Recent Developments
7 North America by Country
  1. 7.1 North America Genetic Disorders Drug Sales by Country
  2. 7.1.1 North America Genetic Disorders Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Genetic Disorders Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Genetic Disorders Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Genetic Disorders Drug Market Size by Country
  6. 7.2.1 North America Genetic Disorders Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Genetic Disorders Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Genetic Disorders Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Genetic Disorders Drug Sales by Country
  2. 8.1.1 Europe Genetic Disorders Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Genetic Disorders Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Genetic Disorders Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Genetic Disorders Drug Market Size by Country
  6. 8.2.1 Europe Genetic Disorders Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Genetic Disorders Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Genetic Disorders Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Genetic Disorders Drug Sales by Country
  2. 9.1.1 Asia-Pacific Genetic Disorders Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Genetic Disorders Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Genetic Disorders Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Genetic Disorders Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Genetic Disorders Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Genetic Disorders Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Genetic Disorders Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Genetic Disorders Drug Sales by Country
  2. 10.1.1 South America Genetic Disorders Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Genetic Disorders Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Genetic Disorders Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Genetic Disorders Drug Market Size by Country
  6. 10.2.1 South America Genetic Disorders Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Genetic Disorders Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Genetic Disorders Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Genetic Disorders Drug Sales by Country
  2. 11.1.1 Middle East and Africa Genetic Disorders Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Genetic Disorders Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Genetic Disorders Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Genetic Disorders Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Genetic Disorders Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Genetic Disorders Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Genetic Disorders Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Genetic Disorders Drug Value Chain Analysis
  2. 12.1.1 Genetic Disorders Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Genetic Disorders Drug Production Mode & Process
  7. 12.2 Genetic Disorders Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Genetic Disorders Drug Distributors
  10. 12.2.3 Genetic Disorders Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst